k1ÌåÓý

ÔÚÏß×Éѯ

Hi,ÎÒÔÚÏß

½Ó´ýÄúËæʱ×Éѯ

Ãâ·ÑÑÝʾ
΢ÐÅ¿Í·þ

²úÆ·×Éѯ£¬¶¨ÖÆÆÊÎö£¬ÓªÒµÏàͬ

×Éѯµç»°:0571-2883-4398

Êý¾ÝÆÊÎö
µç»°×Éѯ

0571-2883-4398

close
Ô¤Ô¼²úÆ·ÑÝʾ
ÇëÍêÉÆÒÔÏÂÐÅÏ¢£¬ÎÒÃǽ«ÁªÏµÄú¾ÙÐÐÑÝʾ
*
*
ÎÒÒÑÔĶÁ²¢Ô޳ɡ¶Òþ˽Õþ²ß¡·
close
Ô¤Ô¼Êý¾ÝÆÊÎö
ÇëÍêÉÆÒÔÏÂÐÅÏ¢£¬ÎÒÃǽ«ÁªÏµÄú¾ÙÐÐÏàͬ
*
*
ÎÒÒÑÔĶÁ²¢Ô޳ɡ¶Òþ˽Õþ²ß¡·

JAMA Network Open: ¾«Éñ¹²²¢Ö¢µÄ±£´æÓ뻼Óжද֢µÄ¶ùͯºÍÇàÉÙÄê±»Õï¶ÏΪ¾«ÉñÆÆËéÖ¢µÄΣº¦ÔöÌíÓйØ

Ðû²¼£º2023-12-12    ä¯ÀÀ£º308 ´Î

µã»÷¡¾Ï·½¿¨Æ¬¡¿¹Ø×¢ÎÒÃÇ~×îÐÂÇ°ÑØ×ÊѶÕùÏÈ¿´

¿ª·ÅתÔØ£¬½Ó´ý¸÷ÈËת·¢µ½Åó٭ȦºÍ΢ÐÅȺ

¿ÉÌí¼ÓС±à΢ÐÅ¡¾13295818509¡¿»ñÈ¡Ô­ÎÄ 



×¢ÖØȱÏÝÓë¶à¶¯ÕÏ°­£¨ADHD£©Ë׳ƶද֢£¬±¬·¢ÓÚ¶ùͯʱÆÚ£¬ÆäÖ÷ÒªÌØÕ÷ΪעÖØÏÔ׿¯ÖÐÄÑÌâ¡¢×¢ÖØÒ»Á¬Ê±¼ä¶ÌÔÝ¡¢Ô˶¯Ì«¹ý»ò¼¤¶¯¡£¶à¶¯Ö¢ÊÇÔÚ¶ùͯÖнÏΪ³£¼ûµÄÒ»ÖÖÕÏ°­£¬Æ仼²¡ÂÊÒ»Ñùƽ³£±¨µÀΪ3%-5%£¬ÄÐÅ®±ÈÀýΪ4:1¡£½üÄêÀ´£¬ADHDÓ뾫ÉñÆÆËéÖ¢Ö®¼äµÄ¹ØÁªÊܵ½Ô½À´Ô½¶àµÄ¹Ø×¢¡£È»¶ø£¬¹ØÓڶද֢»¼Õß¾«Éñ¹²²¢Ö¢ÓëËæºóµÄ¾«ÉñÆÆËéÖ¢Ö®¼ä¹ØÁªµÄÑо¿ÁÈÁÈ¡£

2023Äê11ÔÂ1ÈÕ£¬º«¹ú¼ÃÖݹúÁ¢´óѧ µÄSoo Min Jeon²©Ê¿ºÍÇì±±´óѧµÄSangHun Cha²©Ê¿¼°ÆäÍŶÓÔÚJAMA Network Open£¨IF=13.8)ÉϽÒÏþÁËÌâΪ¡°Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder¡±µÄÎÄÕ£¬Ñо¿Åú×¢£º»¼ÓÐ×¢ÖØȱÏÝÓë¶à¶¯ÕÏ°­ (ADHD) µÄÄêÇỼÕß±£´æ¾«Éñ¹²²¢Ö¢£¬Óë±»Õï¶ÏΪ¾«ÉñÆÆËéÖ¢µÄ½Ï¸ßΣº¦Ïà¹Ø¡£


 ¸ÃÑо¿×ܹ²ÄÉÈëÁË 211 705 ÃûÐÂÕï¶ÏµÄ ADHD »¼Õß¡£157 272 Ãû»¼Õߣ¨74.3%£©ÎªÄÐÐÔ£¬ÄêËêÂþÑÜ×î¸ßµÄÊÇ 5 ÖÁ 9 Ëê¡£»¼Óо«Éñ¹²²¢Ö¢µÄ»¼Õß±»Õï¶ÏΪ¾«ÉñÆÆËéÖ¢µÄΣº¦ÏÔןßÓÚûÓо«ÉñºÏ²¢Ö¢µÄ»¼Õß¡£Ëæןϲ¢Ö¢ÊýÄ¿µÄÔöÌí£¬¾«ÉñÆÆËéÖ¢Ó뾫Éñ¹²²¢Ö¢Ö®¼äµÄ¹ØÁªÐÔÖð½¥ÔöÇ¿¡£¼¸ÖÖ¾«Éñ¼²²¡Ó뾫ÉñÆÆËéÖ¢µÄÉú³¤±£´æ¹ØÁª£¬ÆäÖаüÀ¨×Ô±ÕÖ¢Æ×ϵÕÏ°­£¨ASD£©¡¢ÖÇÁ¦ÕÏ°­¡¢³é¶¯ÕÏ°­¡¢ÒÖÓôÖ¢ºÍË«ÏàÇéÐ÷ÕÏ°­ÎåÖÖ×îΪÏà¹ØµÄ¼²²¡¡£±ðµÄ£¬3244 ÃûûÓо«Éñ¹²²¢Ö¢µÄ»¼ÕßÔÚ¾«ÉñÆÆËéÖ¢±¬·¢Ö®Ç°Ò²ÂÄÀú¹ýÆäËû¾«Éñ¼²²¡¡£


¾«ÉñÆÆËéÖ¢ºÍ¾«ÉñºÏ²¢Ö¢Ö®¼äµÄÁªÏµ


¸ÃÑо¿ÊǵÚÒ»ÏîÊӲ컼Óжද֢µÄ¶ùͯºÍÇàÉÙÄ꾫ÉñÆÆËé֢Σº¦µÄÑо¿£¬ÌØÊâ¹Ø×¢¾«Éñ¹²²¢Ö¢¡£Ñо¿Ö¸³ö»¼Óо«Éñ¹²²¢Ö¢µÄ¶à¶¯Ö¢»¼Õß±ÈûÓй²²¢Ö¢µÄ»¼Õß±»Õï¶ÏΪ¾«ÉñÆÆËéÖ¢µÄΣº¦¸ü¸ß¡£±ðµÄ£¬Ñо¿Ö°Ô±ÊӲ쵽£¬Ëæ׏²²¢Ö¢ÊýÄ¿µÄÔöÌí£¬¾«ÉñÆÆËéÖ¢µÄΣº¦Öð²½ÔöÌí¡£ÎªÁ˸üºÃµØÏàʶ»ùÏßʱûÓо«Éñ¹²²¢Ö¢µÄ»¼Õß¾«ÉñÆÆËéÖ¢µÄÏ£Íû£¬Ñо¿Ö°Ô±¹¹½¨ÁËÕï¶Ï¹ì¼£¡£

֮ǰµÄÑо¿È·¶¨Á˼¸ÖÖ¾«Éñ¼²²¡ÊǾ«ÉñÆÆËéÖ¢Éú³¤µÄΣÏÕÒòËØ£¬Óë¸ÃÑо¿Ð§¹ûÏàÒ»Ö¡£È»¶ø£¬´ËÇ°Ñо¿²¢Ã»ÓÐ˼Á¿³£¼ûµÄ¾«ÉñºÏ²¢Ö¢£¬ÀýÈçÒÖÓôÖ¢ºÍ½¹ÂÇÖ¢¡£±ðµÄ£¬ÓÉÓÚ´ó´ó¶¼Ñо¿¶¼¼¯ÖÐÔÚ»ùÏßµÄΣÏÕÒòËØÉÏ£¬Òò´Ëȱ·¦¹ØÓڴӶද֢µ½¾«ÉñÆÆËéÖ¢µÄÕï¶ÏģʽµÄÖ¤¾Ý¡£Òò´Ë£¬±¾Ñо¿Îª»¼Óжද֢µÄ¶ùͯºÍÇàÉÙÄêÖеļ¸ÖÖ¾«Éñ¹²²¢Ö¢ÓëËæºóµÄ¾«ÉñÆÆËéÖ¢Éú³¤Ö®¼äµÄ¹ØÁªÌṩÁËÌØÁíÍâÖ¤¾Ý¡£

´Ó×¢ÖØȱÏݶදÕÏ°­µ½¾«ÉñÆÆËéÖ¢µÄÕï¶ÏģʽÖо«ÉñºÏ²¢Ö¢µÄ·¢²¡ÂÊ

ÕâÏîÑо¿Åú×¢£¬¾«Éñ¹²²¢Ö¢µÄ±£´æÓ뻼Óжද֢µÄ¶ùͯºÍÇàÉÙÄê±»Õï¶ÏΪ¾«ÉñÆÆËéÖ¢µÄΣº¦ÔöÌíÓйء£ÓÐȤµÄÊÇ£¬ËäÈ»»¼ÕßÔÚADHDÕï¶Ïʱ´úûÓо«Éñ¼²²¡µÄ¹²²¡£¬µ«ÕâЩ¼²²¡µÄ±¬·¢ÔÚ¾«ÉñÆÆËéÖ¢Õï¶Ï֮ǰ»á±»¾­³£ÊӲ쵽¡£ÕâЩ·¢Ã÷Ç¿µ÷ÁË×Ðϸ¼à²âADHD»¼Õߵľ«Éñ²¢¹²Ö¢ÒÔÓÐÓüõÇᾫÉñÆÆËéÖ¢¼ç¸ºµÄÒâÒå¡£

²Î¿¼ÎÄÏ×
Jeon SM, Lee DY, Cha S, Kwon JW. Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder. JAMA Netw Open. 2023 Nov 1;6(11):e2345793. doi: 10.1001/jamanetworkopen.2023.45793. PMID: 38032637; PMCID: PMC10690465.

×ÊѶȪԴ
https://medicalxpress.com/news/2023-12-psychiatric-comorbidity-schizophrenia-young-patients.html


½Ó´ý¼ÓÈëÇ°ÑØ×ÊѶ½»Á÷Ⱥ£¬ÈëȺ·½·¨£º

Ìí¼ÓС±à΢ÐÅ13295818509

±¸×¢£¨ÐÕÃû-ÊÂÇ鵥λ/ԺУ-Ñо¿Æ«Ïò-ÎÄÏ×½»Á÷£©

£¨¿ÉɨÃèÏ·½¶þάÂ룩

ÈëȺ¿ÉÃâ·ÑÌṩÎÄÏ×ÏÂÔØ·þÎñ


ÕÐƸͨ¸æ


Åàѵ¿Î³Ì


Êý¾ÝÆÊÎöÓªÒµ


±àÒ룺ñÒ   ·²

УÉó£ºÕ¹ÁÕÁÕ


È«ÎÄÍê

ËùÓÐ×¢Ã÷À´ÓɵÄÎÄÕ£¬Ö¼ÔÚ·ÖÏí¡¢Èö²¥£¬ÈôÓÐÇÖȨ£¬ÇëʵʱÁªÏµk1ÌåÓý£¬ÎÒÃǽ«¾¡¿ì´¦Öóͷ£

ϲ»¶±¾ÎļǵÃÒ»¼üËÄÁ¬

µãµãÔÞ£¬µãÔÚ¿´£¬µã·ÖÏí£¬µãÊղأ¡

ÍøÕ¾µØͼ
ÓÑÇéÁ´½Ó£º2138cnÌ«Ñô¼¯ÍŹÅÌìÀÖ  ¹ÅÌìÀÖÌ«ÑôÓéÀÖ¼¯ÍÅ  vsportÌåÓýƽ̨  ÖDz©1919ÌåÓý  ÐÓöÎƽ̨  Î¬¶àÀûÑÇÀÏÆ·ÅÆ  Z6×ðÁú  fun88¹ÙÍø  williamÍþÁ®ÑÇÖÞ¹Ù·½  ¹ÅÌìÀÖÌ«ÑôÓéÀÖ¼¯ÍÅ  ATMÓéÀÖ  ×ðÁú¹Ù·½Æ½Ì¨  ±ØÒ»Ô˶¯  ÂÀÊϹó±ö»á  ÃÀʨ¹ó±ö»á